Helen Boudreau

Ms. Helen M.
Boudreau is an Independent Director at Rallybio Corp., an Independent Director at Shattuck Labs, Inc. and a Managing Director at Estuary Ventures LLC.
She is on the Board of Directors at Rallybio LLC, Rallybio Corp., Shattuck Labs, Inc. and Field Trip Health, Inc. Ms. Boudreau was previously employed as an Independent Director by CARA Therapeutics, Inc., an Independent Director by Evaxion Biotech A/S, an Independent Director by Premier, Inc., an Independent Director by Field Trip Health Ltd., an Independent Director by Reunion Neuroscience, Inc., a Chief Operating Officer by Bill & Melinda Gates Medical Research Institute, a Treasurer, Chief Financial & Accounting Officer by Proteostasis Therapeutics, Inc., a Chief Financial Officer by Forma Therapeutics, Inc., a Chief Financial Officer by Novartis Corp., a Chief Financial Officer & VP-Investor Relations by Novartis Oncology, Inc., a Director-Strategic Planning by Tricon Global Restaurants, Inc., a Manager-Engagement by McKinsey & Co., Inc., a Principal by Bank of America Corp., and a Vice President-Finance by Pfizer Inc. She also served on the board at Field Trip Psychedelics, Inc. She received her undergraduate degree from the University of Maryland and an MBA from the University of Virginia Darden School of Business.